Literature DB >> 15162452

Insights into adenoviral vector production kinetics in acoustic filter-based perfusion cultures.

Olivier Henry1, Edwige Dormond, Michel Perrier, Amine Kamen.   

Abstract

One of the major limitations in the production of adenoviral vectors is the reduction in cell-specific productivity observed for increasing cell density at infection in batch cultures. This observation strongly suggests some nutrient depletion and/or metabolite inhibition in the media. These limitations have been partially overcome through other feeding strategies, such as fed-batch and sequential batch operations. To improve these results, we evaluated perfusion as a strategy to increase the volumetric productivity of HEK-293 cell cultures, by allowing productive infection at higher cell densities. An acoustic cell separator was employed in consideration of the increased shear sensitivity of the cells during the infection phase. The effects of perfusion rate and cell density at infection on the production of a recombinant adenovirus expressing the GFP were investigated. The perfusion mode allowed successful infection at cell densities in the range of 2.4-3 x 10(6) cell/mL, while maintaining a similar cell specific productivity (17,900 +/- 2400 VP/cell) to that of a batch infected at a low cell density (5 x 10(5) cell/mL). The highest virus concentrations (4.1 +/- 0.6 x 10(10) VP/mL) were attained for a feed rate of 2 vol/d and constituted a fivefold increase compared to a batch with medium replacement. Rapid assessment of the infection status was achieved through the use of on-line monitoring of respiration, fluorescence, and biovolume. Analysis of the kinetics of nutrient consumption and metabolite production revealed that a reduction in specific productivity is correlated with reduced metabolic activity. Copyright 2004 Wiley Periodicals, Inc.

Mesh:

Year:  2004        PMID: 15162452     DOI: 10.1002/bit.20074

Source DB:  PubMed          Journal:  Biotechnol Bioeng        ISSN: 0006-3592            Impact factor:   4.530


  16 in total

1.  Adenovirus vector production using low-multiplicity infection of 293 cells.

Authors:  Kentaro Yamada; Naoya Morishita; Tomohisa Katsuda; Shuji Kubo; Akinobu Gotoh; Hideki Yamaji
Journal:  Cytotechnology       Date:  2009-07-08       Impact factor: 2.058

2.  Overcoming nutrient limitations for cell-based production of influenza vaccine.

Authors:  Xu-Ping Liu; Ding Huang; Wen-Song Tan; Jian Luo; Ze Chen
Journal:  Hum Vaccin Immunother       Date:  2015       Impact factor: 3.452

3.  Immobilization of 293 cells using porous support particles for adenovirus vector production.

Authors:  Naoya Morishita; Tomohisa Katsuda; Shuji Kubo; Akinobu Gotoh; Hideki Yamaji
Journal:  Cytotechnology       Date:  2010-02-06       Impact factor: 2.058

4.  Histone deacetylase inhibitor trichostatin A enhances the antitumor effect of the oncolytic adenovirus H101 on esophageal squamous cell carcinoma in vitro and in vivo.

Authors:  Junfen Ma; Nan Li; Jimin Zhao; Jing Lu; Yanqiu Ma; Qinghua Zhu; Ziming Dong; Kangdong Liu; Liang Ming
Journal:  Oncol Lett       Date:  2017-04-21       Impact factor: 2.967

5.  A serum-free Vero production platform for a chimeric virus vaccine candidate.

Authors:  Inn H Yuk; Gina B Lin; Hui Ju; Inesse Sifi; Yvonne Lam; Armida Cortez; Danny Liebertz; J Michael Berry; Richard M Schwartz
Journal:  Cytotechnology       Date:  2006-11-16       Impact factor: 2.058

6.  Metabolic and kinetic analyses of influenza production in perfusion HEK293 cell culture.

Authors:  Emma Petiot; Danielle Jacob; Stephane Lanthier; Verena Lohr; Sven Ansorge; Amine A Kamen
Journal:  BMC Biotechnol       Date:  2011-09-01       Impact factor: 2.563

Review 7.  Bioreactors for high cell density and continuous multi-stage cultivations: options for process intensification in cell culture-based viral vaccine production.

Authors:  Felipe Tapia; Daniel Vázquez-Ramírez; Yvonne Genzel; Udo Reichl
Journal:  Appl Microbiol Biotechnol       Date:  2016-01-13       Impact factor: 4.813

8.  Scalable Lentiviral Vector Production Using Stable HEK293SF Producer Cell Lines.

Authors:  Aziza P Manceur; Howard Kim; Vanja Misic; Nadejda Andreev; July Dorion-Thibaudeau; Stéphane Lanthier; Alice Bernier; Sonia Tremblay; Anne-Marie Gélinas; Sophie Broussau; Rénald Gilbert; Sven Ansorge
Journal:  Hum Gene Ther Methods       Date:  2017-11-21       Impact factor: 2.396

9.  Production of a Foot-and-Mouth Disease Vaccine Antigen Using Suspension-Adapted BHK-21 Cells in a Bioreactor.

Authors:  Soonyong Park; Ji Yul Kim; Kyoung-Hwa Ryu; Ah-Young Kim; Jaemun Kim; Young-Joon Ko; Eun Gyo Lee
Journal:  Vaccines (Basel)       Date:  2021-05-13

10.  Serum-Free Suspension Culture of MDCK Cells for Production of Influenza H1N1 Vaccines.

Authors:  Ding Huang; Wen-Juan Peng; Qian Ye; Xu-Ping Liu; Liang Zhao; Li Fan; Kang Xia-Hou; Han-Jing Jia; Jian Luo; Lin-Ting Zhou; Bei-Bei Li; Shi-Lei Wang; Wen-Ting Xu; Ze Chen; Wen-Song Tan
Journal:  PLoS One       Date:  2015-11-05       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.